Pharmacokinetics in design of polymeric drug delivery systems
- 1 September 1994
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 31 (2) , 163-171
- https://doi.org/10.1016/0168-3659(94)00025-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Therapeutic effects of superoxide dismutase derivatives modified with mono- or polysaccharides on hepatic injury induced by ischemia/reperfusionBiochemical and Biophysical Research Communications, 1992
- Demonstration of the Receptor-mediated Hepatic Uptake of Dextran in MiceJournal of Pharmacy and Pharmacology, 1992
- Preparation and properties of the immunoconjugate composed of anti-human colon cancer monoclonal antibody and mitomycin C-dextran conjugateBioconjugate Chemistry, 1992
- Tumor Localization and in vivo Antitumor Activity of the Immunoconjugate Composed of Anti‐human Colon Cancer Monoclonal Antibody and Mitomycin C‐Dextran ConjugateJapanese Journal of Cancer Research, 1991
- Biochemical and biopharmaceutical properties of macromolecular conjugates of uricase with dextran and polyethylene glycol.CHEMICAL & PHARMACEUTICAL BULLETIN, 1990
- Physicochemical properties and antitumor activities of polymeric prodrugs of mitomycin C with different regeneration ratesJournal of Controlled Release, 1989
- Soluble macromolecular carriers for the delivery of antitumour drugsAdvanced Drug Delivery Reviews, 1989
- Development of a novel polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate with anionic charge. II. Disposition and pharmacokinetics following intravenous and intramuscular administrationInternational Journal of Pharmaceutics, 1987
- Mitomycin C-dextran conjugate: a novel high molecular weight pro-drug of mitomycin CJournal of Pharmacy and Pharmacology, 1980
- 2-Imino-2-methoxyethyl 1-thioglycosides: new reagents for attaching sugars to proteinsBiochemistry, 1976